Prime Therapeutics Urges Caution On Mandates Of Abuse-Deterrent Formulations Of Opioids Citing Value Concerns Post author:Sam Post published:July 20, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like FDA Calls Bay Area Global Blood Therapeutics' Sickle Cell Drug a Breakthrough January 8, 2018 Amgen to Build New $300M Facility After Tax Changes February 1, 2018 Metabolon To Establish Metabolomics Lab In Qatar To Serve Markets In The Middle East May 2, 2017